O&P Clinicians

O&P care is cost effective—it is a saver, not a coster to insurers.

The O&P community has the facts but how do we communicate this documented fact that timely O&P intervention does in fact result in fewer co-morbidities and lower healthcare costs for patients and payers. The key message is that “Mobility Saves.” Dobson DaVanzo’s study commissioned by the Amputee Coalition, funded by AOPA and publicly released August 27, 2013 makes the cost effective case for O&P intervention and proves that “Mobility Saves.” We knew that intuitively—now Medicare’s own costs and figures prove it irrefutably.

Why Is It Important To You?

Medicare and other payers more and more are looking for the solid evidence that certain treatment pathways deliver solid outcomes for the patient and that those outcomes are cost effective. Your ability to provide O&P services and be secure in receiving and retaining reimbursements will increasingly be tied to evidence-based practices. But its one thing to have the facts and quite another to make sure those facts are known to those individuals whose decisions will affect patient care at all levels.

The O&P community has the facts but how do we communicate this documented fact that timely O&P intervention does in fact result in fewer co-morbidities and lower healthcare costs for patients and payers? The key message is that “Mobility Saves.”

 

Learn More

Learn about Prosthetic Devices

Learn about Orthotic Devices